Back to SNDX
Candriam S.C.A. SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$31.5M
Q3 2026
Peak value
$37M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $14.2M |
| Q4 2025 | $19.4M |
| Q4 2025 | $19.4M |
| Q1 2026 | $21.6M |
| Q2 2026 | $37M |
| Q3 2026 | $31.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $31.5M | 1.67M | — | — |
| Q2 2026 | $37M | 1.70M | — | — |
| Q1 2026 | $21.6M | 925.3K | — | — |
| Q4 2025 | $19.4M | 925.3K | — | — |
| Q4 2025 | $19.4M | 925.3K | — | — |
| Q3 2025 | $14.2M | 925.3K | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$118.9M
$116.1M
$114.7M
$114.2M
$114.2M
$111.4M